Filtered By:
Specialty: Endocrinology
Condition: Osteoporosis
Drug: Insulin

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
Conclusions World population is aging and the increase in life expectancy is often unhealthy. In particular, musculoskeletal aging, which leads to sarcopenia and osteoporosis, has several causes such as changes in body composition, inflammation, and hormonal imbalance. Sarcopenia, osteoporosis, and more frequently, sarcopenic obesity are commonly associated with aging and frequently closely linked each other, often leading to the development of a frailty syndrome. Frailty syndrome favors an increased risk of loss function in daily activities, for cardiovascular diseases, cancers, falls, and mortality. As the number of eld...
Source: Frontiers in Endocrinology - April 23, 2019 Category: Endocrinology Source Type: research

Muscle-bone interactions: from experimental models to the clinic? A critical update
Publication date: Available online 23 October 2015 Source:Molecular and Cellular Endocrinology Author(s): Michaël R. Laurent, Vanessa Dubois, Frank Claessens, Sabine M.P. Verschueren, Dirk Vanderschueren, Evelien Gielen, Ferran Jardí Bone is a biomechanical tissue shaped by forces from muscles and gravitation. Simultaneous bone and muscle decay and dysfunction (osteosarcopenia or sarco-osteoporosis) is seen in ageing, numerous clinical situations including after stroke or paralysis, in neuromuscular dystrophies, glucocorticoid excess, or in association with vitamin D, growth hormone/insulin like growth factor or...
Source: Molecular and Cellular Endocrinology - October 24, 2015 Category: Endocrinology Source Type: research